Aprea director awarded RSUs and stock options
Aprea Therapeutics, Inc. director Michael Grissinger received equity compensation in the form of restricted stock units and stock options.
Rhea-AI Filing Summary
Aprea Therapeutics, Inc. director Michael Grissinger received equity compensation in the form of restricted stock units and stock options. On June 16, 2026, he was granted 3,135 restricted stock units that will vest and be settled in common stock on June 16, 2027, if he continues serving on the board through that date.
He also received stock options for 12,555 shares of common stock at an exercise price of $0.7293 per share, vesting in full on June 16, 2027 and expiring on June 16, 2036, subject to the same service-based condition. After these grants, he directly holds 6,024 shares of common stock and 12,555 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 15,690 shares
Grant/Award
2 txns
Insider
Grissinger Michael
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 12,555 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 3,135 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to Buy) — 12,555 contracts (Direct);
Common Stock — 6,024 shares (Direct)
Footnotes (2)
- F1. These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- F2. The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
Key Figures
Restricted stock units granted: 3,135 shares
Stock options granted: 12,555 options
Option exercise price: $0.7293 per share
+3 more
6 metrics
Restricted stock units granted
3,135 shares
Granted June 16, 2026; vest June 16, 2027
Stock options granted
12,555 options
Granted June 16, 2026; underlying common stock
Option exercise price
$0.7293 per share
Stock options granted June 16, 2026
Option expiration date
June 16, 2036
Stock options for 12,555 shares
Common shares held after grants
6,024 shares
Direct ownership following June 16, 2026 awards
Options held after grants
12,555 options
Direct derivative holdings following the grant
Key Terms
restricted stock units, vest, stock options, exercise price, +1 more
5 terms
restricted stock units financial
"These shares represent restricted stock units which were granted on June 16, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vest financial
"which will vest and be settled in common stock on June 16, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
stock options financial
"The option vests in full on June 16, 2027"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price": "0.7293""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-06-16T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Aprea Therapeutics (APRE) grant to director Michael Grissinger?
Aprea Therapeutics granted director Michael Grissinger 3,135 restricted stock units and stock options for 12,555 shares. The options carry a $0.7293 exercise price and both awards are subject to future vesting conditions tied to continued board service.
When do Michael Grissinger’s Aprea Therapeutics (APRE) restricted stock units vest?
Grissinger’s 3,135 restricted stock units vest and settle in common stock on June 16, 2027. Vesting requires his continued service on Aprea Therapeutics’ board of directors through and including that date, with potential acceleration only under specified conditions.
What are the key terms of Michael Grissinger’s Aprea Therapeutics (APRE) stock options?
He received options for 12,555 shares of Aprea common stock at a $0.7293 exercise price. These options vest in full on June 16, 2027, require continued board service, and expire on June 16, 2036 if not exercised earlier.
Is Michael Grissinger’s Aprea Therapeutics (APRE) Form 4 transaction an open-market trade?
No, the Form 4 reports compensation-related equity awards, not open-market trades. The 3,135 restricted stock units and 12,555 stock options were granted at no cash cost to him, with vesting based on continued board service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
